Eli Lilly & Co.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $6.54B | $4.58B | $3.67B | $3.87B | $3.83B | $4.02B | $5.92B | $5.99B |
| Accounts Receivable | $4.55B | $4.03B | $3.51B | $3.23B | $3.43B | $3.34B | $3.60B | $3.49B |
| Inventory | $4.46B | $3.56B | $3.45B | $2.74B | $2.93B | $2.64B | $2.30B | $2.52B |
| Total Current Assets | $19.20B | $15.10B | $12.57B | $11.93B | $13.10B | $13.04B | $14.25B | $14.84B |
| Property, Plant & Equipment | $8.83B | $8.25B | $8.05B | $7.96B | $7.98B | $7.76B | $7.76B | $7.94B |
| Goodwill | $4.37B | $3.97B | $4.04B | $1.76B | $1.52B | $1.50B | $1.43B | $1.42B |
| Intangible Assets (Excl. Goodwill) | $4.03B | $4.36B | $5.03B | $2.88B | $2.81B | $3.19B | — | — |
| Total Assets | $44.98B | $38.81B | $35.57B | $36.31B | $35.25B | $34.40B | $33.66B | $31.00B |
| Liabilities | ||||||||
| Accounts Payable | $1.41B | $1.35B | $1.34B | $1.13B | $1.12B | $1.19B | $1.13B | $1.07B |
| Total Current Liabilities | $14.54B | $10.99B | $8.23B | $9.74B | $8.92B | $8.39B | $8.93B | $6.93B |
| Long-Term Debt | $9.94B | $8.37B | $7.97B | $5.33B | $4.20B | $5.52B | $5.46B | $6.77B |
| Total Liabilities | $33.39B | $24.80B | $21.00B | $20.93B | $17.62B | $19.63B | $20.12B | $18.58B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $13.89B | $16.05B | $16.01B | $16.48B | $16.99B | $16.09B | $14.90B | $12.73B |
| Total Stockholders' Equity | $11.59B | $14.01B | $14.57B | $15.37B | $17.63B | $14.77B | $13.54B | $12.42B |